GZMB and neoplasm: Immunohistochemistry (IHC) analyses of the tumor samples obtained on day 6 after the beginning of the therapy were performed to evaluate the levels of tumor vascularization, proliferation, hypoxia, apoptosis, immune infiltration (granzyme B-positive cells), and necrosis (Figure 2a).